Organon & Co | OGN - Trade Debtors

Stock Price
7.29
Daily Change
-0.22 -2.93%
Monthly
-19.89%
Yearly
-52.95%
Q1 Forecast
7.85

Organon & Co reported $1.48B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Celltrion KRW 1.51T 128.69B Sep/2025
Cspc Pharmaceutical CNY 8.85B 769.12M Jun/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 5M 4.96M Sep/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
Kangmei Pharma CNY 3.15B 295.48M Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.65M 162K Jun/2025
Merck USD 12.12B 596M Sep/2025
Neuren Pharmaceuticals AUD 20.71M 155.01M Jun/2025
Novartis USD 8.98B 192M Sep/2025
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Organon & Co USD 1.48B 0 Sep/2025
Ovoca Bio EUR 447K 113K Jun/2022
Pharma Mar EUR 41.76M 26.1M Sep/2025
Qiagen NV USD 402.61M 9.05M Dec/2025
Sartorius EUR 344.7M 48.5M Sep/2025
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 121.49M 18.12M Mar/2025